查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1953459

數位腦健康市場－全球產業規模、佔有率、趨勢、機會與預測：組成部分、功能、最終用戶、地區和競爭格局（2021-2031年）

Digital Brain Health Market - Global Industry Size, Share, Trends, Opportunity, & Forecast Segmented By Components, By Functionalities, By End-User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球數位腦健康市場預計將從 2025 年的 2,236.1 億美元大幅成長至 2031 年的 3,901.3 億美元，複合年成長率為 9.72%。

該領域涵蓋多種技術解決方案，包括用於評估和治療神經系統疾病的診斷軟體和數位療法。市場成長的主要驅動力是全球人口老化和神經退化性疾病盛行率的不斷上升，從而催生了對可擴展遠距遠端醫療方案的強勁需求。此外，專業人士的廣泛應用也推動了這一成長。根據美國心理學會預測，到2025年，56%的心理學家將使用人工智慧工具輔助工作，這顯示這些技術正逐漸融入標準臨床實務。

市場概覽
預測期 2027-2031
市場規模：2025年 2236.1億美元
市場規模：2031年 3901.3億美元
複合年成長率：2026-2031年 9.72%
成長最快的細分市場 醫院和診所
最大的市場 北美洲

然而，該行業面臨著許多與監管核准所需的嚴格臨床檢驗相關的重大障礙。達到與傳統藥物相同的證據標準是一個複雜的過程，這常常導致產品上市延遲，並限制了健保報銷機會。此外，保護患者敏感的神經系統資料隱私仍然是一項持續的挑戰。這些隱私問題可能會削弱用戶信任，並使遵守國際衛生法規變得更加複雜，從而阻礙市場快速擴張。

市場促進因素

神經系統和精神疾病盛行率的不斷上升是全球數位腦健康市場的主要驅動力。隨著預期壽命的延長，與老齡化相關的認知能力下降和慢性精神疾病的負擔日益加重，給傳統醫療保健系統帶來了難以承受的壓力，並迫切需要可擴展的數位干預措施。根據阿茲海默症協會於2025年3月發布的《2025年阿茲海默症健康狀況報告》，預計約有720萬65歲及以上的美國人患有老年失智症失智症，這凸顯了便捷的遠距監測和治療工具的重要性。這種人口結構的變化正在推動模式轉移，數位平台正成為臨床和家庭環境中標準神經系統護理的重要組成部分。

同時，大量資金流入正在加速先進腦健康技術的研發和商業化。在技​​術成熟和清晰的商業化路徑的支持下，投資者越來越認知到該領域的潛力。根據 Fierce Healthcare（2025 年 1 月）通報，2024 年，心理健康是美國數位健康市場中資金籌措最多的臨床適應症，吸引了 14 億美元的創業投資資金。這些資金對於進行嚴格的臨床試驗至關重要，而這些試驗是獲得監管部門核准和保險覆蓋所必需的。此外，支付方政策的改善也增強了該領域的資金基礎。根據《新英格蘭心理學家》（2025 年 1 月）報道，聯邦醫療保險（Medicare）已開始涵蓋經 FDA核准的數位心理健康療法。這是一個重要的監管里程碑，顯著降低了投資風險，並促進了更多療法進入市場。

市場挑戰

全球數位腦健康市場受到嚴格的臨床檢驗和監管合核准要求的顯著限制。與典型的健康和保健應用程式不同，數位療法和診斷軟體必須透過與傳統藥物相同的證據標準來證明其安全性和有效性。這種高准入門檻要求進行大規模、高成本的臨床試驗，從而延緩了產品的商業化。由此導致的漫長研發週期阻礙了新解決方案的上市，並嚴重限制了永續收入模式和廣泛應用所需的報銷途徑。

這種複雜性直接影響了專業人士的採納率，因為醫療專業人員往往不願意使用缺乏政府嚴格檢驗的工具。根據美國醫學會 (AMA) 預測，到 2025 年，47% 的醫生會將「加強法律規範」視為提升大眾對醫療人工智慧工具信任度的首要步驟。除非人們對數位介入的臨床有效性建立起堅實的信心，否則醫療服務提供者不太可能使用這些技術。這種懷疑態度造成了嚴重的通路瓶頸，有效地阻礙了市場快速擴張以滿足日益成長的神經系統疾病治療需求。

市場趨勢

將人工智慧 (AI) 應用於預測分析和個人化治療是推動全球數位腦健康市場發展的關鍵趨勢，使製藥公司能夠最佳化治療方案的研發和病人參與。利用先進演算法分析複雜資料集有助於識別數位生物標記，並開發傳統調查方法難以實現的個人化介入策略。這種向數據驅動型精準醫療的轉變，得益於製藥業對運算能力的大規模投資。根據 Graphite Digital 於 2025 年 5 月發布的報告《2025 年製藥業數位化趨勢：人工智慧、全通路與病患參與》，68% 的製藥業數位化決策者表示已投資於人工智慧驅動的洞察，這凸顯了他們致力於利用機器學習技術來推進臨床和營運的策略決心。

同時，隨著雇主日益意識到員工心理健康對經濟的影響，企業心理健康和認知韌性解決方案的成長正在推動市場擴張。各組織正積極採用數位化平台，為壓力管理和認知能力提升提供擴充性的遠端支持，有效地將職場轉變為腦健康工具的主要通路。這種重視使得數位化介入措施能夠惠及傳統臨床環境之外的更廣泛人群。根據商業健康集團 (Business Group on Health) 於 2025 年 5 月發布的《2025 年雇主福祉戰略調查》，100% 的受訪大型企業已將心理健康納入其福祉戰略，47% 的企業將其列為計劃中的首要組成部分，這證實了雇主主導的舉措在推動市場需求方面發揮著核心作用。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球數位腦健康市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按組件（軟體、裝置）
    • 按功能分類（臨床功能、行政功能、護理計劃/健康管理、臨床決策支援 (CDS)、電子健康記錄 (EHR)、電子處方箋、財務功能、遠端醫療、其他）
    • 依最終使用者（醫院、診所、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美數位腦健康市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲數位腦健康市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區數位腦健康市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲數位腦健康市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章 南美洲數位腦健康市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球數位腦健康市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Advanced Oncotherapy PLC
  • Cerner Corporation
  • Core Solutions, Inc.
  • Danfysik A/S
  • Hitachi Ltd
  • Holmusk Inc
  • IBA Worldwide
  • Qualifacts Systems, Inc.
  • International Business Machines Corporation
  • Linus Health Inc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 16991

The Global Digital Brain Health Market is projected to expand significantly, growing from USD 223.61 Billion in 2025 to USD 390.13 Billion by 2031, reflecting a compound annual growth rate of 9.72%. This sector encompasses a range of technological solutions, such as diagnostic software and digital therapeutics, which are developed to assess and treat neurological conditions. The market's upward trajectory is primarily driven by an aging global population and the increasing prevalence of neurodegenerative disorders, creating a strong demand for scalable remote care options. Additionally, professional adoption is reinforcing this growth; according to the American Psychological Association, 56% of psychologists reported using artificial intelligence tools to assist with their work in 2025, demonstrating the integration of these technologies into standard clinical practice.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 223.61 Billion
Market Size 2031USD 390.13 Billion
CAGR 2026-20319.72%
Fastest Growing SegmentHospitals & Clinics
Largest MarketNorth America

However, the industry faces substantial hurdles related to the rigorous clinical validation necessary for regulatory approval. Meeting evidence standards comparable to those of traditional pharmaceuticals is a complex process that frequently delays product launches and restricts reimbursement opportunities. Furthermore, safeguarding the privacy of sensitive patient neurological data remains a persistent challenge. These privacy concerns can erode user trust and complicate compliance with international health regulations, thereby impeding the rapid expansion of the market.

Market Driver

The escalating prevalence of neurological disorders and mental health conditions serves as the primary catalyst for the Global Digital Brain Health Market. As life expectancy rises, the increasing burden of age-related cognitive decline and chronic psychiatric issues is placing unsustainable pressure on traditional healthcare systems, creating an urgent need for scalable digital interventions. According to the Alzheimer's Association's '2025 Alzheimer's Disease Facts and Figures' report from March 2025, an estimated 7.2 million Americans aged 65 and older are living with Alzheimer's dementia, highlighting the critical necessity for accessible, remote monitoring and therapeutic tools. This demographic shift is forcing a paradigm change where digital platforms are becoming essential components of standard neurological care across both clinical and home settings.

Simultaneously, a strong influx of financial capital is accelerating the development and commercialization of advanced brain health technologies. Investors are increasingly recognizing the sector's potential, supported by technological maturity and clearer paths to monetization. According to Fierce Healthcare in January 2025, mental health remained the top-funded clinical indication in the U.S. digital health market in 2024, securing $1.4 billion in venture financing. This funding is vital for the rigorous clinical trials required for regulatory clearance and reimbursement eligibility. Moreover, the financial landscape is being bolstered by improved payer policies; according to New England Psychologist in January 2025, Medicare began covering FDA-approved digital mental health therapeutics, a regulatory milestone that significantly de-risks investment and encourages further market entry.

Market Challenge

The Global Digital Brain Health Market is significantly constrained by the rigorous clinical validation and regulatory compliance required for approval. Unlike general wellness applications, digital therapeutics and diagnostic software must demonstrate safety and efficacy through evidentiary standards comparable to traditional pharmaceuticals. This high barrier to entry necessitates extensive and costly clinical trials that delay product commercialization. Consequently, these extended development timelines slow the introduction of new solutions to the market and severely limit the availability of reimbursement pathways, which are critical for sustainable revenue models and widespread accessibility.

This complexity directly impacts professional adoption rates, as practitioners often hesitate to utilize tools that lack robust, government-backed verification. According to the American Medical Association, in 2025, 47% of physicians ranked increased regulatory oversight as the primary action necessary to improve their trust in healthcare AI tools. Without this established confidence in the clinical validity of digital interventions, providers are less likely to prescribe these technologies. This skepticism creates a substantial bottleneck in distribution, effectively preventing the market from scaling rapidly to meet the growing demand for neurological care.

Market Trends

The integration of Artificial Intelligence for predictive analytics and personalized treatment is a major trend driving the Global Digital Brain Health Market, enabling pharmaceutical companies to optimize therapeutic development and patient engagement. Advanced algorithms are utilized to analyze complex datasets, facilitating the identification of digital biomarkers and the creation of tailored intervention strategies that traditional methodologies cannot match. This shift towards data-driven precision medicine is evidenced by substantial industry investment in computational capabilities. According to Graphite Digital's 'Pharma Digital Trends 2025: AI, Omnichannel, & Patient Engagement' report from May 2025, 68% of senior digital decision-makers in the pharmaceutical industry reported investing in AI-powered insights, underscoring the sector's strategic commitment to leveraging machine learning for clinical and operational advancements.

Simultaneously, the growth of corporate mental wellness and cognitive resilience solutions is accelerating market expansion as employers increasingly recognize the economic impact of workforce psychological health. Organizations are actively adopting digital platforms to provide scalable, remote support for stress management and cognitive performance, effectively transitioning the workplace into a primary distribution channel for brain health tools. This prioritization ensures that digital interventions are accessible to a broader demographic beyond traditional clinical settings. According to the Business Group on Health's '2025 Employer Well-being Strategy Survey' released in May 2025, 100% of surveyed large employers included mental health in their well-being strategy, with 47% identifying it as the most important component of their program, confirming the central role of employer-sponsored initiatives in driving demand.

Key Market Players

  • Advanced Oncotherapy PLC
  • Cerner Corporation
  • Core Solutions, Inc.
  • Danfysik A/S
  • Hitachi Ltd
  • Holmusk Inc
  • IBA Worldwide
  • Qualifacts Systems, Inc.
  • International Business Machines Corporation
  • Linus Health Inc

Report Scope

In this report, the Global Digital Brain Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Brain Health Market, By Components

  • Software
  • Devices

Digital Brain Health Market, By Functionalities

  • Clinical Functionality
  • Administrative Functionality
  • Care Plans/Health Management
  • Clinical Decision Support (CDS)
  • Electronic Health Records (EHR)
  • E-Prescribing
  • Financial Functionality
  • Telehealth
  • Other

Digital Brain Health Market, By End-User

  • Hospitals & Clinics
  • Other

Digital Brain Health Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Brain Health Market.

Available Customizations:

Global Digital Brain Health Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital Brain Health Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Components (Software, Devices)
    • 5.2.2. By Functionalities (Clinical Functionality, Administrative Functionality, Care Plans/Health Management, Clinical Decision Support (CDS), Electronic Health Records (EHR), E-Prescribing, Financial Functionality, Telehealth, Other)
    • 5.2.3. By End-User (Hospitals & Clinics, Other)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Digital Brain Health Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Components
    • 6.2.2. By Functionalities
    • 6.2.3. By End-User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Digital Brain Health Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Components
        • 6.3.1.2.2. By Functionalities
        • 6.3.1.2.3. By End-User
    • 6.3.2. Canada Digital Brain Health Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Components
        • 6.3.2.2.2. By Functionalities
        • 6.3.2.2.3. By End-User
    • 6.3.3. Mexico Digital Brain Health Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Components
        • 6.3.3.2.2. By Functionalities
        • 6.3.3.2.3. By End-User

7. Europe Digital Brain Health Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Components
    • 7.2.2. By Functionalities
    • 7.2.3. By End-User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Digital Brain Health Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Components
        • 7.3.1.2.2. By Functionalities
        • 7.3.1.2.3. By End-User
    • 7.3.2. France Digital Brain Health Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Components
        • 7.3.2.2.2. By Functionalities
        • 7.3.2.2.3. By End-User
    • 7.3.3. United Kingdom Digital Brain Health Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Components
        • 7.3.3.2.2. By Functionalities
        • 7.3.3.2.3. By End-User
    • 7.3.4. Italy Digital Brain Health Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Components
        • 7.3.4.2.2. By Functionalities
        • 7.3.4.2.3. By End-User
    • 7.3.5. Spain Digital Brain Health Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Components
        • 7.3.5.2.2. By Functionalities
        • 7.3.5.2.3. By End-User

8. Asia Pacific Digital Brain Health Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Components
    • 8.2.2. By Functionalities
    • 8.2.3. By End-User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Digital Brain Health Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Components
        • 8.3.1.2.2. By Functionalities
        • 8.3.1.2.3. By End-User
    • 8.3.2. India Digital Brain Health Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Components
        • 8.3.2.2.2. By Functionalities
        • 8.3.2.2.3. By End-User
    • 8.3.3. Japan Digital Brain Health Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Components
        • 8.3.3.2.2. By Functionalities
        • 8.3.3.2.3. By End-User
    • 8.3.4. South Korea Digital Brain Health Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Components
        • 8.3.4.2.2. By Functionalities
        • 8.3.4.2.3. By End-User
    • 8.3.5. Australia Digital Brain Health Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Components
        • 8.3.5.2.2. By Functionalities
        • 8.3.5.2.3. By End-User

9. Middle East & Africa Digital Brain Health Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Components
    • 9.2.2. By Functionalities
    • 9.2.3. By End-User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Digital Brain Health Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Components
        • 9.3.1.2.2. By Functionalities
        • 9.3.1.2.3. By End-User
    • 9.3.2. UAE Digital Brain Health Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Components
        • 9.3.2.2.2. By Functionalities
        • 9.3.2.2.3. By End-User
    • 9.3.3. South Africa Digital Brain Health Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Components
        • 9.3.3.2.2. By Functionalities
        • 9.3.3.2.3. By End-User

10. South America Digital Brain Health Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Components
    • 10.2.2. By Functionalities
    • 10.2.3. By End-User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Digital Brain Health Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Components
        • 10.3.1.2.2. By Functionalities
        • 10.3.1.2.3. By End-User
    • 10.3.2. Colombia Digital Brain Health Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Components
        • 10.3.2.2.2. By Functionalities
        • 10.3.2.2.3. By End-User
    • 10.3.3. Argentina Digital Brain Health Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Components
        • 10.3.3.2.2. By Functionalities
        • 10.3.3.2.3. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Digital Brain Health Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Advanced Oncotherapy PLC
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Cerner Corporation
  • 15.3. Core Solutions, Inc.
  • 15.4. Danfysik A/S
  • 15.5. Hitachi Ltd
  • 15.6. Holmusk Inc
  • 15.7. IBA Worldwide
  • 15.8. Qualifacts Systems, Inc.
  • 15.9. International Business Machines Corporation
  • 15.10. Linus Health Inc

16. Strategic Recommendations

17. About Us & Disclaimer